These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 23884378)

  • 1. Endothelin 1 in cancer: biological implications and therapeutic opportunities.
    Rosanò L; Spinella F; Bagnato A
    Nat Rev Cancer; 2013 Sep; 13(9):637-51. PubMed ID: 23884378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of endothelin-1 in the sympathetic nervous system in the heart.
    Lehmann LH; Stanmore DA; Backs J
    Life Sci; 2014 Nov; 118(2):165-72. PubMed ID: 24632477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-1 differentially directs lineage specification of adipose- and bone marrow-derived mesenchymal stem cells.
    Lee MS; Wang J; Yuan H; Jiao H; Tsai TL; Squire MW; Li WJ
    FASEB J; 2019 Jan; 33(1):996-1007. PubMed ID: 30096039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of endothelin-1 in tumor angiogenesis.
    Bagnato A; Spinella F
    Trends Endocrinol Metab; 2003 Jan; 14(1):44-50. PubMed ID: 12475611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin-1 and tumour development.
    Asham EH; Loizidou M; Taylor I
    Eur J Surg Oncol; 1998 Feb; 24(1):57-60. PubMed ID: 9542519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permissive role of endothelin receptors in tumor metastasis.
    Said N; Theodorescu D
    Life Sci; 2012 Oct; 91(13-14):522-7. PubMed ID: 22846215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late endosomal/lysosomal targeting and lack of recycling of the ligand-occupied endothelin B receptor.
    Oksche A; Boese G; Horstmeyer A; Furkert J; Beyermann M; Bienert M; Rosenthal W
    Mol Pharmacol; 2000 Jun; 57(6):1104-13. PubMed ID: 10825380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cells direct human mesenchymal stem cells for osteo- and chondro-lineage differentiation through endothelin-1 and AKT signaling.
    Tsai TL; Wang B; Squire MW; Guo LW; Li WJ
    Stem Cell Res Ther; 2015 May; 6(1):88. PubMed ID: 25998005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1: a multifunctional molecule in cancer.
    Grant K; Loizidou M; Taylor I
    Br J Cancer; 2003 Jan; 88(2):163-6. PubMed ID: 12610497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gbetagamma-mediated prostacyclin production and cAMP-dependent protein kinase activation by endothelin-1 promotes vascular smooth muscle cell hypertrophy through inhibition of glycogen synthase kinase-3.
    Taurin S; Hogarth K; Sandbo N; Yau DM; Dulin NO
    J Biol Chem; 2007 Jul; 282(27):19518-25. PubMed ID: 17513863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids regulate the expression of the human osteoblastic endothelin A receptor gene.
    Börcsök I; Schairer HU; Sommer U; Wakley GK; Schneider U; Geiger F; Niethard FU; Ziegler R; Kasperk CH
    J Exp Med; 1998 Nov; 188(9):1563-73. PubMed ID: 9802968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin 1 is a growth factor for corneal endothelium.
    Chollet P; Malecaze F; Gouzi L; Arne JL; Plouet J
    Exp Eye Res; 1993 Nov; 57(5):595-600. PubMed ID: 8282046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin receptor antagonists.
    Nelson JB
    World J Urol; 2005 Feb; 23(1):19-27. PubMed ID: 15654644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms.
    Wang L; Wu H; Wang L; Zhang H; Lu J; Liang Z; Liu T
    Cancer Lett; 2017 Jul; 398():24-36. PubMed ID: 28400334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1 is synthesized and inhibits cyclic adenosine monophosphate- dependent anion secretion by an autocrine/paracrine mechanism in gallbladder epithelial cells.
    Fouassier L; Chinet T; Robert B; Carayon A; Balladur P; Mergey M; Paul A; Poupon R; Capeau J; Barbu V; Housset C
    J Clin Invest; 1998 Jun; 101(12):2881-8. PubMed ID: 9637723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does targeting the lipophilic milieu provide advantages for an endothelin antagonist?
    Pollock DM; Boesen EI; Black SM
    Mol Interv; 2009 Apr; 9(2):75-8. PubMed ID: 19401539
    [No Abstract]   [Full Text] [Related]  

  • 17. Endothelin-1 reduces catabolic activity of human mesenchymal stem/stromal cells during chondro- and osteo-lineage differentiation.
    Weishar R; Lee MS; Fontana G; Hematti P; Li WJ
    Biochem Biophys Res Commun; 2020 Aug; 529(2):180-185. PubMed ID: 32703408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin therapeutics in cancer: Where are we?
    Rosanò L; Bagnato A
    Am J Physiol Regul Integr Comp Physiol; 2016 Mar; 310(6):R469-75. PubMed ID: 26818060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGFs: crucial factors that regulate tumour initiation and progression.
    Jing Q; Wang Y; Liu H; Deng X; Jiang L; Liu R; Song H; Li J
    Cell Prolif; 2016 Aug; 49(4):438-47. PubMed ID: 27383016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin (ET)-1 inhibits nicotinamide adenine dinucleotide phosphate oxidase activity in human abdominal aortic endothelial cells: a novel function of ETB1 receptors.
    Dammanahalli JK; Sun Z
    Endocrinology; 2008 Oct; 149(10):4979-87. PubMed ID: 18535108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.